Prevalence and Prevention of Reproducibility Deficiencies in Life Sciences Research: Large-Scale Meta-Analyses

N, Mansour; Balas, E. Andrew; Yang, Frances M.; Vernon, Marlo M.

doi:10.12659/msm.922016

Cited by 3 publications

(1 citation statement)

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among other available indicators are federal research funding received, completed clinical trials, patents issued, or start-up companies creations, to name a few. Those can help in driving a multi-faceted approach that could make “[r]esearch quality improvement [… ] a continuous and comprehensive process, from the design and conduct of research to the publication of results.” [ 10 ] Adopting comprehensive measures not based solely on bibliometrics factors will help in reducing deficiencies, increasing research productivity, and enabling meritorious scientific discoveries.…”

Section: Introduction – Need For Multidimensional Assessment Of Resea...mentioning

confidence: 99%

Data Integration for the Study of Outstanding Productivity in Biomedical Research

Aubert

Balas

Townsend

et al. 2022

Procedia Computer Science

View full text Add to dashboard Cite

Section: Introduction – Need For Multidimensional Assessment Of Resea...mentioning

confidence: 99%

Data Integration for the Study of Outstanding Productivity in Biomedical Research

Aubert

Balas

Townsend

et al. 2022

Procedia Computer Science

View full text Add to dashboard Cite

Evidence-Based Research Integrity Policy

Redman

2023

Reconstructing Research Integrity

View full text Add to dashboard Cite

Strategic policy options to improve quality and productivity of biomedical research

Balas,

De Leo,

Shaw

2024

Polit. life sci.

View full text Add to dashboard Cite

Emerging societal expectations from biomedical research and intensifying international scientific competition are becoming existential matters. Based on a review of pertinent evidence, this article analyzes challenges and formulates public policy recommendations for improving productivity and impact of life sciences. Critical risks include widespread quality defects of research, particularly non-reproducible results, and narrow access to scientifically sound information giving advantage to health misinformation. In funding life sciences, the simultaneous shift to nondemocratic societies is an added challenge. Simply spending more on research will not be enough in the global competition. Considering the pacesetter role of the federal government, five national policy recommendations are put forward: (i) funding projects with comprehensive expectations of reproducibility; (ii) public–private partnerships for contemporaneous quality support in laboratories; (iii) making research institutions accountable for quality control; (iv) supporting new quality filtering standards for scientific journals and repositories, and (v) establishing a new network of centers for scientific health communications.

show abstract

Prevalence and Prevention of Reproducibility Deficiencies in Life Sciences Research: Large-Scale Meta-Analyses

Cited by 3 publications

References 71 publications

Data Integration for the Study of Outstanding Productivity in Biomedical Research

Data Integration for the Study of Outstanding Productivity in Biomedical Research

Evidence-Based Research Integrity Policy

Strategic policy options to improve quality and productivity of biomedical research

Contact Info

Product

Resources

About